General and Specific Functions of Exonic Splicing Silencers in Splicing Control

Molecular Cell

Volumn 23, Issue 1, 2006, Pages 61-70

  Wang, Zefeng ^a   Xiao, Xinshu ^a   Van Nostrand, Eric ^a   Burge, Christopher B ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

RNA

Indexed keywords

RIBONUCLEOPROTEIN; RIBONUCLEOPROTEIN A1; SPLICING FACTOR 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; DECISION MAKING; EXON; GENE CONTROL; GENE FUNCTION; GENE LOCATION; GENE MUTATION; GENE SILENCING; GENETIC CONSERVATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INTRON; REPORTER GENE;

3' UNTRANSLATED REGIONS; ALTERNATIVE SPLICING; ANIMALS; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; EXONS; GENE SILENCING; HUMANS; MICE; MODELS, BIOLOGICAL; RNA SPLICING; SILENCER ELEMENTS, TRANSCRIPTIONAL;

EID: 33745501015     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2006.05.018     Document Type: Article

References (32)

1. Bai Y., Lee D., Yu T., and Chasin L.A. Control of 3′ splice site choice in vivo by ASF/SF2 and hnRNP A1. Nucleic Acids Res. 27 (1999) 1126-1134
2. Baralle D., and Baralle M. Splicing in action: assessing disease causing sequence changes. J. Med. Genet. 42 (2005) 737-748
3. Black D.L. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72 (2003) 291-336
4. Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., and Thompson C.B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74 (1993) 597-608
5. Burd C.G., and Dreyfuss G. RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J. 13 (1994) 1197-1204
6. Caceres J.F., Stamm S., Helfman D.M., and Krainer A.R. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265 (1994) 1706-1709
7. Cascino I., Papoff G., De Maria R., Testi R., and Ruberti G. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J. Immunol. 156 (1996) 13-17
8. Chen C.D., Kobayashi R., and Helfman D.M. Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat beta-tropomyosin gene. Genes Dev. 13 (1999) 593-606
9. Cheng C., and Sharp P.A. Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion. Mol. Cell. Biol. 26 (2006) 362-370
10. Del Gatto-Konczak F., Olive M., Gesnel M.C., and Breathnach R. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol. Cell. Biol. 19 (1999) 251-260
11. Fairbrother W.G., Yeh R.F., Sharp P.A., and Burge C.B. Predictive identification of exonic splicing enhancers in human genes. Science 297 (2002) 1007-1013
12. Fairbrother W.G., Holste D., Burge C.B., and Sharp P.A. Single nucleotide polymorphism-based validation of exonic splicing enhancers. PLoS Biol. 2 (2004) E268 10.1371/journal.pbio.0020268
13. Forrest S.T., Barringhaus K.G., Perlegas D., Hammarskjold M.L., and McNamara C.A. Intron retention generates a novel Id3 isoform that inhibits vascular lesion formation. J. Biol. Chem. 279 (2004) 32897-32903
14. Fu X.D., Mayeda A., Maniatis T., and Krainer A.R. General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5′ and 3′ splice site selection. Proc. Natl. Acad. Sci. USA 89 (1992) 11224-11228
15. Gabut M., Mine M., Marsac C., Brivet M., Tazi J., and Soret J. The SR protein SC35 is responsible for aberrant splicing of the E1alpha pyruvate dehydrogenase mRNA in a case of mental retardation with lactic acidosis. Mol. Cell. Biol. 25 (2005) 3286-3294
16. Ge H., and Manley J.L. A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell 62 (1990) 25-34
17. Graveley B.R., Hertel K.J., and Maniatis T. A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers. EMBO J. 17 (1998) 6747-6756
18. Han K., Yeo G., An P., Burge C.B., and Grabowski P.J. A combinatorial code for splicing silencing: UAGG and GGGG motifs. PLoS Biol. 3 (2005) e158 10.1371/journal.pbio.0030158
19. Karolchik D., Baertsch R., Diekhans M., Furey T.S., Hinrichs A., Lu Y.T., Roskin K.M., Schwartz M., Sugnet C.W., Thomas D.J., et al. The UCSC Genome Browser Database. Nucleic Acids Res. 31 (2003) 51-54
20. Klamt B., Koziell A., Poulat F., Wieacker P., Scambler P., Berta P., and Gessler M. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. Hum. Mol. Genet. 7 (1998) 709-714
21. Krainer A.R., Conway G.C., and Kozak D. The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites. Cell 62 (1990) 35-42
22. Lejeune F., Cavaloc Y., and Stevenin J. Alternative splicing of intron 3 of the serine/arginine-rich protein 9G8 gene. Identification of flanking exonic splicing enhancers and involvement of 9G8 as a trans-acting factor. J. Biol. Chem. 276 (2001) 7850-7858
23. Martinez-Contreras R., Fisette J.F., Nasim F.U., Madden R., Cordeau M., and Chabot B. Intronic binding sites for hnRNP A/B and hnRNP F/H proteins stimulate pre-mRNA splicing. PLoS Biol. 4 (2006) e21 10.1371/journal.pbio.0040021
24. Matlin A.J., Clark F., and Smith C.W. Understanding alternative splicing: towards a cellular code. Nat. Rev. Mol. Cell Biol. 6 (2005) 386-398
25. Mayeda A., and Krainer A.R. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell 68 (1992) 365-375
26. Nagoshi R.N., McKeown M., Burtis K.C., Belote J.M., and Baker B.S. The control of alternative splicing at genes regulating sexual differentiation in D. melanogaster. Cell 53 (1988) 229-236
27. Schneider D., Tuerk C., and Gold L. Selection of high affinity RNA ligands to the bacteriophage R17 coat protein. J. Mol. Biol. 228 (1992) 862-869
28. Sugnet C.W., Kent W.J., Ares Jr. M., and Haussler D. Transcriptome and genome conservation of alternative splicing events in humans and mice. Pac. Symp. Biocomput. 2004 (2004) 66-77
29. Wang Z., Rolish M.E., Yeo G., Tung V., Mawson M., and Burge C.B. Systematic identification and analysis of exonic splicing silencers. Cell 119 (2004) 831-845
30. Xie X., Lu J., Kulbokas E.J., Golub T.R., Mootha V., Lindblad-Toh K., Lander E.S., and Kellis M. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434 (2005) 338-345
31. Yeo G., and Burge C.B. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 11 (2004) 377-394
32. Yeo G., Holste D., Kreiman G., and Burge C.B. Variation in alternative splicing across human tissues. Genome Biol. 5 (2004) R74